GH1 and intracranial hypertension: While there have been reports of adverse side effects, such as intracranial hypertension associated with higher doses of GH and supraphysiologic IGF-Iz, there is a lack of clinical data demonstrating a direct dose-response effect (5,6,7,8,9).